Cardiac Contractility Modulation Therapy in Patients with Amyloid Cardiomyopathy and Heart Failure, Case Report, Review of the Biophysics of CCM Function, and AMY-CCM Registry Presentation

Cardiac amyloidosis may result in an aggressive form of heart failure (HF). Cardiac contractility modulation (CCM) has been shown to be a concrete therapeutic option in patients with symptomatic HF, but there is no evidence of its application in patients with cardiac amyloidosis. We present the case...

Descripción completa

Detalles Bibliográficos

Autores principales:	Marchese, Procolo, Gennaro, Francesca, Mazzotta, Giovanni, Acciarri, Claudia, Amabili, Stenio, Bonanni, Carlo, D’Antonio, Antonella, Delfino, Domenico, Di Vito, Luca, Partemi, Manrico, Pascucci, Riccardo, Romandini, Andrea, Scalone, Giancarla, Silenzi, Simona, Grossi, Pierfrancesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917884/ https://www.ncbi.nlm.nih.gov/pubmed/36769832 http://dx.doi.org/10.3390/jcm12031184